PAM9- COST COMPARISON OF TREATING RHEUMATOID ARTHRITIS PATIENTS WITH COX-2 INHIBITORS OR NSAIDS IN A MANAGED CARE POPULATION
Abstract
Authors
E Liao G Kester D Huse
E Liao G Kester D Huse
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now